» Articles » PMID: 23690707

Magnetic Field Interactions of Copper-containing Intrauterine Devices in 3.0-Tesla Magnetic Resonance Imaging: in Vivo Study

Overview
Journal Korean J Radiol
Specialty Radiology
Date 2013 May 22
PMID 23690707
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: An ex vivo study found a copper-containing intrauterine device (IUD) to be safe for women undergoing an MRI examination at a 3.0-T field. No significant artifacts caused by the metallic implant were detected. However, there are still no in vivo data about these concerns. The aim of this study was to evaluate 3.0-T magnetic field interactions of copper-containing IUDs in vivo.

Materials And Methods: Magnetic field interactions and potential adverse events were evaluated in 33 women using a questionnaire-based telephone survey. Two experienced radiologists performed artifact evaluation on MR images of the pelvis.

Results: Eighteen patients were eligible for the survey. One patient reported a dislocation of the IUD after the MR examination. All other patients had no signs of field interactions. No IUD-related artifacts were found.

Conclusion: MRI at 3.0-T is possible for women with copper-containing IUDs. However, consulting a gynecologist to check the correct position of the IUD and exclude complications after an MR examination is highly recommended. High-quality clinical imaging of the female pelvis can be performed without a loss in image quality.

Citing Articles

An in-vivo study of the safety of copper-containing intrauterine devices in 3.0 Tesla magnetic resonance imaging.

Moy J, Landon M, Vigilante J, Lehmann B, DeChambeau A, Rohlfing F Abdom Radiol (NY). 2024; 49(12):4592-4599.

PMID: 39023566 PMC: 11522044. DOI: 10.1007/s00261-024-04493-4.


Case series demonstrating in vivo MR safety of stainless steel (Chinese/Ring) IUDs.

Thomas S, Hindman N BJR Case Rep. 2022; 8(3):20210165.

PMID: 36101733 PMC: 9461733. DOI: 10.1259/bjrcr.20210165.


Risk assessment of copper-containing contraceptives: the impact for women with implanted intrauterine devices during clinical MRI and CT examinations.

Neumann W, Uhrig T, Malzacher M, Kossmann V, Schad L, Zoellner F Eur Radiol. 2018; 29(6):2812-2820.

PMID: 30456586 DOI: 10.1007/s00330-018-5864-6.


Safety of intrauterine devices in MRI.

Bussmann S, Luechinger R, Froehlich J, von Weymarn C, Reischauer C, Koh D PLoS One. 2018; 13(10):e0204220.

PMID: 30300364 PMC: 6177157. DOI: 10.1371/journal.pone.0204220.


Contraception concerns, utilization and counseling needs of women with a history of breast cancer: a qualitative study.

Mody S, Panelli D, Hulugalle A, Su H, Gorman J Int J Womens Health. 2017; 9:507-512.

PMID: 28790868 PMC: 5531568. DOI: 10.2147/IJWH.S136120.


References
1.
Michaely H, Attenberger U, Kramer H, Nael K, Reiser M, Schoenberg S . Abdominal and pelvic MR angiography. Magn Reson Imaging Clin N Am. 2007; 15(3):301-14, v-vi. DOI: 10.1016/j.mric.2007.06.001. View

2.
Craven I, Griffiths P, Hoggard N . Magnetic resonance imaging of epilepsy at 3 Tesla. Clin Radiol. 2011; 66(3):278-86. DOI: 10.1016/j.crad.2010.10.010. View

3.
Stankiewicz J, Glanz B, Healy B, Arora A, Neema M, Benedict R . Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging. 2009; 21(2):e50-6. PMC: 3043123. DOI: 10.1111/j.1552-6569.2009.00449.x. View

4.
Muhler M, Taupitz M . [How safe is magnetic resonance imaging in patients with contraceptive implants?]. Radiologe. 2005; 46(7):574-8. DOI: 10.1007/s00117-005-1212-3. View

5.
Andersson K, Lindell K, Odlind V, Milsom I . Perforations with intrauterine devices. Report from a Swedish survey. Contraception. 1998; 57(4):251-5. DOI: 10.1016/s0010-7824(98)00029-8. View